Andy Sassine
CIK: 0001515322
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 15, 2025ARCT
Arcturus Therapeutics Holdings Inc.
Purchase(P)Direct1.2K shares at avg. $16.56$20K - Jul 17, 2025ICAD
ICAD INC
Disposition(D)Direct1.2M shares- - Jan 3, 2025ICAD
ICAD INC
Award(A)DirectDirector Stock Option (right to buy)
30K shares- - Dec 16, 2024ARCT
Arcturus Therapeutics Holdings Inc.
Award(A)DirectEmployee Stock Option (right to buy)
60K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 15, 2025 |  ARCT Arcturus Therapeutics Holdings Inc. | Purchase(P) | 1,238 | $16.56 | $20,499 | Direct |
| Jul 17, 2025 |  ICAD ICAD INC | Disposition(D) | 1,198,382 | - | - | Direct |
| Jan 3, 2025 | ICAD ICAD INC | Award(A) Director Stock Option (right to buy) | 30,000 | - | - | Direct |
| Dec 16, 2024 | ARCT Arcturus Therapeutics Holdings Inc. | Award(A) Employee Stock Option (right to buy) | 60,000 | - | - | Direct |
1-4 of 4 transactions
About SASSINE ANDY
SASSINE ANDY (SEC CIK 0001515322) files insider reports with the SEC as Chief Financial Officer of Arcturus Therapeutics Holdings Inc. (ARCT) and Director of ICAD INC (ICAD).
Signal8 holds 5 ownership filings by SASSINE ANDY, all Form 4s, filed between Dec 18, 2024 and Aug 20, 2025. Those filings report 4 transactions, from Dec 16, 2024 to Aug 15, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on SASSINE ANDY's filings is in NASHUA, NH.
Recent filings by SASSINE ANDY
Other insiders filing for Arcturus Therapeutics Holdings Inc. (ARCT)
- HOLMES EDWARD W, Director
- FARRELL PETER C, Director
- BARLOW JAMES F, Director
- Markels John, Director
- Slaoui Moncef, Director
- Marquet Magda, Director